Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-κB signaling pathway

Molecular Medicine Reports

Volumn 10, Issue 2, 2014, Pages 1007-1012

  Lee, Kyu Shik ^a   Lee, Do Hyung ^a   Chun, So Young ^a   Nam, Kyung Soo ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Breast cancer; Cyclooxygenase 2; Matrix metalloproteinase 9; Metastasis; Proton beam

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; PROTON; PTGS2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MDA MB 231 CELL; METASTASIS INHIBITION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTON RADIATION; SIGNAL TRANSDUCTION; BREAST TUMOR; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; IONIZING RADIATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RADIATION RESPONSE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTONS; RADIATION, IONIZING; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 84903303801     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2259     Document Type: Article

References (34)

1. Lim YK, Park BS, Lee SK, Kim KR and Yang TK: A proton beam irradiation method for a uniform dose distribution over a sample volume. J Korean Phys Soc 48: 777-780, 2006. (Pubitemid 43681064)
2. Suit H and Urie M: Proton beams in radiation therapy. J Natl Cancer Inst 84: 155-164, 1992.
3. Nieves-Alicea R, Colburn NH, Simeone AM and Tari AM: Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Breast Cancer Res Treat 114: 203-209, 2009.
4. Duffy MJ, McGowan PM and Gallagher WM: Cancer invasion and metastasis: changing views. J Pathol 214: 283-293, 2008. (Pubitemid 351212383)
5. Yoon SO, Kim MM and Chung AS: Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem 276: 20085-20092, 2001.
6. Chan G, Boyle JO, Yang EK, et al: Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991-994, 1999. (Pubitemid 29135955)
7. Tucker ON, Dannenberg AJ, Yang EK, et al: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59: 987-990, 1999. (Pubitemid 29135954)
8. Adhim Z, Matsuoka T, Bito T, et al: In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines. Br J Cancer 105: 393-402, 2011.
9. Bocca C, Bozzo F, Bassignana A and Miglietta A: Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines. Mol Cell Biochem 350: 59-70, 2011.
10. Kang JH, Song KH, Jeong KC, et al: Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells. BMC Cancer 11: 334, 2011.
11. Kundu N and Fulton AM: Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res 62: 2343-2346, 2002. (Pubitemid 34411715)
12. Morita Y, Hata K, Nakanishi M, Nishisho T, Yura Y and Yoneda T: Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol 41: 885-892, 2012.
13. Kim S, Kim SH, Hur SM, et al: Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells. J Ethnopharmacol 126: 252-257, 2009.
14. Lee KS, Mo, J. Y., Shon, Y. H., Nam, K. S.: Inhibition of metastatic activities in human breast cancer cells irradiated by a proton beam. J Korean Phys Soc 59: 653-656, 2011.
15. Park SY, Kim YH, Kim Y and Lee SJ: Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-kappaB activation in TPA-induced breast cancer cells. J Cell Biochem 113: 3653-3662, 2012.
16. Takahra T, Smart DE, Oakley F and Mann DA: Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int J Biochem Cell Biol 36: 353-363, 2004. (Pubitemid 37487769)
17. Shin Y, Yoon SH, Choe EY, et al: PMA-induced up-regulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells. Exp Mol Med 39: 97-105, 2007. (Pubitemid 46356010)
18. Lee KS, Shin JS and Nam KS: Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells. Mol Biol Rep 40: 5959-5966, 2013.
19. Cho HJ, Kang JH, Kwak JY, et al: Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 28: 1104-1110, 2007. (Pubitemid 47072197)
20. Garg A and Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16: 1053-1068, 2002. (Pubitemid 34618844)
21. Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V and Girolomoni G: ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 174: 5047-5056, 2005.
22. Park SK, Hwang YS, Park KK, Park HJ, Seo JY and Chung WY: Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Carcinogenesis 30: 1225-1233, 2009.
23. Cragg GM, Newman DJ and Weiss RB: Coral reefs, forests, and thermal vents: the worldwide exploration of nature for novel antitumor agents. Semin Oncol 24: 156-163, 1997. (Pubitemid 27181123)
24. Jang JY, Jeon YK and Kim CW: Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 10: 391, 2010.
25. Degner SC, Kemp MQ, Bowden GT and Romagnolo DF: Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr 136: 421-427, 2006. (Pubitemid 43228296)
26. Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP and White BA: Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs. Breast Cancer Res Treat 132: 75-85, 2012.
27. Sheng S, Qiao M and Pardee AB: Metastasis and AKT activation. J Cell Physiol 218: 451-454, 2009.
28. Agarwal A, Das K, Lerner N, et al: The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene 24: 1021-1031, 2005. (Pubitemid 40313879)
29. Kumar R, Alam S, Chaudhari BP, et al: Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1. Carcinogenesis 34: 647-657, 2013.
30. Shao W, Wang D and He J: The role of gene expression profiling in early-stage non-small cell lung cancer. J Thorac Dis 2: 89-99, 2010.
31. Altundag K and Ibrahim NK: Aromatase inhibitors in breast cancer: an overview. Oncologist 11: 553-562, 2006. (Pubitemid 43967611)
32. Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y and Muschel RJ: Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 157: 1777-1783, 2000.
33. Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10: 415-433, 2000.
34. Chang C and Werb Z: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11: S37-S43, 2001.